Mangoceuticals (MGRX) Operating Expenses (2023 - 2026)

Mangoceuticals' Operating Expenses history runs 4 years deep, the most recent figure standing at $3.2 million for Q1 2026.

• In Q1 2026, Operating Expenses fell 31.97% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $16.5 million (up 57.73% YoY), while the FY2025 annual figure was $18.3 million, up 118.9% from the prior year.
• Operating Expenses came in at $3.2 million for Q1 2026 at Mangoceuticals, up from $415214.0 in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $7.6 million in Q3 2025 to a low of $415214.0 in Q4 2025.
• A 4-year average of $3.0 million and a median of $2.5 million in 2024 frame the typical range for Operating Expenses.
• On a YoY basis, Operating Expenses climbed as much as 312.54% in 2025 and fell as far as 76.38% in 2025.
• Mangoceuticals' Operating Expenses stood at $2.7 million in 2023, then plunged by 35.15% to $1.8 million in 2024, then slumped by 76.38% to $415214.0 in 2025, then surged by 659.93% to $3.2 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $3.2 million, $415214.0, and $7.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison